ストックスクリーナーアプリを入手
231.50
1.76%
4.00
アフターアワーズ：
232.22
0.72
+0.31%
前日終値:
$227.50
開ける：
$228.42
24時間の取引高:
8.25M
Relative Volume:
1.28
時価総額：
$409.15B
収益：
$61.16B
当期純損益:
$4.20B
株価収益率:
97.80
EPS:
2.3671
ネットキャッシュフロー:
$19.68B
1週間 パフォーマンス:
+3.61%
1か月 パフォーマンス:
+4.87%
6か月 パフォーマンス:
+14.91%
1年 パフォーマンス:
+19.67%
1日の値動き範囲:
$228.00
$234.74
1週間の範囲:
$218.05
$234.74
52週間の値動き範囲:
$164.39
$244.81
Abbvie Inc Stock (ABBV) Company Profile
Compare ABBV vs LLY, JNJ, AZN, NVS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
231.50 | 402.08B | 61.16B | 4.20B | 19.68B | 2.3671 |
|
LLY
Lilly Eli Co
|
1,040.00 | 929.27B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
243.45 | 589.19B | 94.19B | 26.80B | 19.70B | 11.05 |
|
AZN
Astrazeneca Plc
|
205.55 | 317.06B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
163.10 | 307.56B | 54.72B | 14.02B | 15.32B | 7.1855 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-08 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2026-01-07 | 再開されました | UBS | Neutral |
| 2025-12-10 | アップグレード | HSBC Securities | Hold → Buy |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-11-04 | ダウングレード | DZ Bank | Buy → Hold |
| 2025-10-14 | ダウングレード | Erste Group | Buy → Hold |
| 2025-10-01 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-09-17 | アップグレード | Berenberg | Hold → Buy |
| 2025-08-12 | 再開されました | Piper Sandler | Overweight |
| 2025-08-07 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2025-05-14 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-04-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-10 | 再開されました | BofA Securities | Neutral |
| 2024-12-05 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-11-04 | アップグレード | Argus | Hold → Buy |
| 2024-10-17 | 開始されました | Bernstein | Mkt Perform |
| 2024-06-05 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-05-17 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-01-29 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | ダウングレード | HSBC Securities | Buy → Hold |
| 2023-12-11 | アップグレード | Goldman | Neutral → Buy |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-10-30 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 再開されました | UBS | Neutral |
| 2023-09-29 | 開始されました | Raymond James | Outperform |
| 2023-07-25 | 開始されました | William Blair | Mkt Perform |
| 2023-07-14 | 開始されました | HSBC Securities | Buy |
| 2023-04-05 | ダウングレード | Argus | Buy → Hold |
| 2023-03-01 | 開始されました | Guggenheim | Buy |
| 2023-02-22 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | アップグレード | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | 開始されました | Credit Suisse | Outperform |
| 2022-11-08 | ダウングレード | Societe Generale | Buy → Hold |
| 2022-08-01 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | 開始されました | SVB Leerink | Underperform |
| 2022-05-06 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2022-02-28 | ダウングレード | UBS | Buy → Neutral |
| 2022-02-03 | 繰り返されました | BMO Capital Markets | Outperform |
| 2022-02-03 | 繰り返されました | Barclays | Equal Weight |
| 2022-02-03 | 繰り返されました | BofA Securities | Neutral |
| 2022-02-03 | 繰り返されました | Goldman | Neutral |
| 2022-01-13 | 開始されました | Redburn | Buy |
| 2022-01-12 | 繰り返されました | BMO Capital Markets | Outperform |
| 2021-12-09 | 再開されました | Wells Fargo | Overweight |
| 2021-11-23 | アップグレード | Societe Generale | Hold → Buy |
| 2021-07-27 | 再開されました | Truist | Buy |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
| 2020-11-10 | 再開されました | Bernstein | Outperform |
| 2020-09-29 | 開始されました | Berenberg | Hold |
| 2020-06-23 | アップグレード | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | アップグレード | Argus | Hold → Buy |
| 2020-05-18 | 再開されました | BofA/Merrill | Neutral |
| 2020-05-12 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-05-11 | 再開されました | Morgan Stanley | Overweight |
| 2020-04-20 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | ダウングレード | Societe Generale | Buy → Hold |
| 2020-02-27 | 開始されました | Barclays | Equal Weight |
| 2020-02-06 | 開始されました | Mizuho | Buy |
| 2020-01-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | 繰り返されました | Cowen | Outperform |
| 2019-09-26 | アップグレード | Citigroup | Neutral → Buy |
| 2019-08-20 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | 開始されました | Goldman | Neutral |
| 2019-04-29 | アップグレード | BMO Capital Markets | Underperform → Market Perform |
すべてを表示
Abbvie Inc (ABBV) 最新ニュース
AbbVie (ABBV) stock price closes near $232 after immunology pipeline talk — what to watch next week - Bez Kabli
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off - The Motley Fool
DDD Partners LLC Cuts Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie stock price climbs again after Botox lawsuit; what ABBV traders watch next - Bez Kabli
AbbVie (NYSE:ABBV) Trading 1.8% HigherTime to Buy? - MarketBeat
AbbVie Inc (ABBV) Shares Up 3% on Feb 13 - GuruFocus
AbbVie Advances New Toxin-Based Therapy in Ventral Hernia Trial: What Investors Should Watch - TipRanks
ABBV: Key data for lutikizumab, RINVOQ, and IBD combos will drive next-gen immunology advances - TradingView
Where is AbbVie Inc. (ABBV) headed according to the Street? - MSN
AbbVie Deal Crowns 25 Years of Determination; Commercial Leap Is the Next Task, Says Glenn Saldanha - ET Pharma
Where is AbbVie Inc. (ABBV) Headed According to the Street? - Yahoo Finance
Metis Global Partners LLC Has $22.53 Million Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Public Sector Pension Investment Board - MarketBeat
Freemont Management S.A. Trims Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie (NYSE:ABBV) Shares Up 3%What's Next? - MarketBeat
1 reason I'm never selling AbbVie stock - MSN
AbbVie (ABBV) Challenges HHS Over Botox Medicare Price Negotiati - GuruFocus
AbbVie sues Medicare for selecting Botox for price talks (ABBV) - Seeking Alpha
Varma Mutual Pension Insurance Co Has $61 Million Stake in AbbVie Inc. $ABBV - MarketBeat
1 Reason I'm Never Selling AbbVie Stock - The Globe and Mail
Savvy Advisors Inc. Raises Holdings in AbbVie Inc. $ABBV - MarketBeat
Is It Too Late To Consider AbbVie (ABBV) After Its Strong Multi Year Run? - Yahoo Finance
Illinois Municipal Retirement Fund Acquires 19,779 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. (ABBV) Achieves Record Net Sales on Diversified Growth Platform - Yahoo Finance
Atria Investments Inc Decreases Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie sues US health agency over Botox price controls - WHTC
Abbvie sues US health agency over Botox - whbl.com
AbbVie Sues Medicaid, HHS Over Botox Fair Price Controls - Law360
Evercore ISI Cuts AbbVie Inc. (ABBV) PT, Says Consensus for 2026 and 2027 Still Looks Beatable - Insider Monkey
Evercore ISI cuts AbbVie Inc. (ABBV) PT, says consensus for 2026 and 2027 still looks beatable - MSN
AbbVie Sues HHS Over Selection of Botox for Medicare Price Cuts - Bloomberg Law News
AbbVie sues US Health Department over Botox price controls - marketscreener.com
AbbVie sues US health agency over Botox - marketscreener.com
AbbVie sues U.S. Department of Health and Human Services over selection of Botox for IRA Medicare drug negotiations - marketscreener.com
AbbVie Updates Phase 2 Elezanumab Study in Acute Cervical Spinal Cord Injury: What Investors Should Watch - TipRanks
P/E Ratio Insights for AbbVie - Benzinga
The 5 Most Interesting Analyst Questions From AbbVie's Q4 Earnings Call - Finviz
Rhumbline Advisers Trims Stock Position in AbbVie Inc. $ABBV - MarketBeat
Krilogy Financial LLC Raises Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Stratos Wealth Partners LTD. Has $41.28 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Cibc World Market Inc. Acquires 60,635 Shares of AbbVie Inc. $ABBV - MarketBeat
58,432 Shares in AbbVie Inc. $ABBV Purchased by Caprock Group LLC - MarketBeat
ING Groep NV Purchases 528,196 Shares of AbbVie Inc. $ABBV - MarketBeat
Assessing AbbVie (ABBV) Valuation After Strong Q4 Results And New Rinvoq Filings - Sahm
The 5 Most Interesting Analyst Questions From AbbVie’s Q4 Earnings Call - Yahoo Finance
AbbVie stock price rises as analysts reset targets and Wall Street waits on delayed jobs data - TechStock²
AbbVie’s $100bn deal aligns drug pricing with domestic manufacturing goals - Yahoo Finance
Here's What Will Drive AbbVie's Top-line Growth in 2026 - The Globe and Mail
Here's Why AbbVie (ABBV) is a Strong Value Stock - Yahoo Finance
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Wealthfront Advisers LLC Has $40.61 Million Position in AbbVie Inc. $ABBV - MarketBeat
Abbvie Inc (ABBV) 財務データ
収益
当期純利益
現金流量
EPS
0.50%
0.45%
大文字化:
|
ボリューム (24 時間):